Dr. Tomas J. Philipson is currently at The University of Chicago where he holds the Daniel Levin Chair of Public Policy. He is an Angel investor in the health care companies and sits on several boards of directors in this space.
In 2017-2020 he was on leave from the University to serve full-time at The White House as a Member, the Vice Chairman, and Acting Chairman of The President's Council of Economic Advisers.
He was a co-founder of Precision Health Economics LLC, located throughout the US, Canada, and Europe before it was sold in 2015.
He has received numerous worldwide research awards and is a two-time winner of the highest award of his field, the Arrow Award of The International Health Economics Association. Other awards include the Garfield Award for Economic Research, the Premio Haralambos Simeonidis from the Brazilian Economic Association and the Milken Institute's Distinguished Economic Research Award.
He served as a health care advisor to Senator McCain's 2008 presidential campaign. He was senior economic advisor to the heads of the Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS), and was appointed to the Key Indicator Commission by the Speaker of the House of Representatives in 2012. He was a scientific advisor to the House of Representatives initiative 21st Century Cures in 2015 and The Biden Cancer Initiative in 2017.
Frequent popular press contributions include Forbes where he has a standing op-ed column, The Economist, The Wall Street Journal and The New York Times, CNN, CBNC, Fox News, Bloomberg, CSPAN.
He received a B.A. in mathematics from Uppsala University in Sweden, an MA and PhD from the Wharton School and University of Pennsylvania.
• Current economic policy issues
• Health Care
• Medical innovation
• Pharmaceutical markets